Ringene Biopharma

BiotechnologySeries AShanghai, China

Latest round

Series A

Last raised

Sep 2020

Total raised

Undisclosed

Investors

2

About Ringene Biopharma

Established in 2017 and based in Shanghai, China, Ringene Biopharma is a biotechnology company that engaged in research and development of innovative anti-tumor drugs. The core team members have experience in drug discovery, tumor biology, project management and operations. Ringene Biopharma focuses on providing a variety of single-agent or combination drug solutions for drug-resistant patients with tumors. Based on a structural biology-guided drug design platform, the company focuses on key signaling proteins of RTK-MAPK pathway resistance and has established a pipeline of preclinical drug candidates for research and development.

Who invested in Ringene Biopharma

2 investors across 1 round

See all investors in Ringene Biopharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Sep 2, 2020

    Amount

    Undisclosed

    Investors

    Locked

Questions about Ringene Biopharma

Who invested in Ringene Biopharma?

Ringene Biopharma has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Ringene Biopharma raised?

Ringene Biopharma has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Ringene Biopharma last raise money?

Ringene Biopharma's most recent round on record is a Series A, in Sep 2020.

What does Ringene Biopharma do?

Established in 2017 and based in Shanghai, China, Ringene Biopharma is a biotechnology company that engaged in research and development of innovative anti-tumor drugs.

Where is Ringene Biopharma headquartered?

Ringene Biopharma is headquartered in Shanghai, China.

Which VCs invest in companies like Ringene Biopharma?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Ringene Biopharma's stage. Their profiles are linked below.

Raising like Ringene Biopharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.